These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32052596)

  • 1. A roadmap for neurodevelopmental disease modeling for non-stem cell biologists.
    Ernst C
    Stem Cells Transl Med; 2020 May; 9(5):567-574. PubMed ID: 32052596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
    Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
    Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.
    Taoufik E; Kouroupi G; Zygogianni O; Matsas R
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine. iPSC disease modeling.
    Soldner F; Jaenisch R
    Science; 2012 Nov; 338(6111):1155-6. PubMed ID: 23197518
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular barriers to processes of genetic reprogramming and cell transformation.
    Chestkov IV; Khomyakova EA; Vasilieva EA; Lagarkova MA; Kiselev SL
    Biochemistry (Mosc); 2014 Dec; 79(12):1297-307. PubMed ID: 25716723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
    Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
    Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications.
    Erharter A; Rizzi S; Mertens J; Edenhofer F
    FEBS Lett; 2019 Dec; 593(23):3353-3369. PubMed ID: 31663609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instant neurons: directed somatic cell reprogramming models of central nervous system disorders.
    Qiang L; Inoue K; Abeliovich A
    Biol Psychiatry; 2014 Jun; 75(12):945-51. PubMed ID: 24525100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders.
    Adams JW; Cugola FR; Muotri AR
    Physiology (Bethesda); 2019 Sep; 34(5):365-375. PubMed ID: 31389776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
    Liu G; David BT; Trawczynski M; Fessler RG
    Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances.
    McCaughey-Chapman A; Connor B
    Stem Cells Dev; 2018 Dec; 27(24):1674-1692. PubMed ID: 30343634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of somatic cells: iPS and iN cells.
    Broccoli V
    Prog Brain Res; 2017; 230():53-68. PubMed ID: 28552235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of somatic cell reprogramming.
    Wang Y; Bi Y; Gao S
    Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges.
    Seah YF; El Farran CA; Warrier T; Xu J; Loh YH
    Int J Mol Sci; 2015 Dec; 16(12):28614-34. PubMed ID: 26633382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Insight into Reprogramming Barriers to iPSC Generation.
    Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating pediatric disorders with induced pluripotent stem cells.
    Durbin MD; Cadar AG; Chun YW; Hong CC
    Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.